Company Filing History:
Years Active: 2004
Title: Haijuan Li: Innovator in HIV Protease Inhibitor Quantification
Introduction
Haijuan Li is a notable inventor based in Fishers, IN (US). He has made significant contributions to the field of biomedical research, particularly in the quantification of HIV protease inhibitors. His innovative approach has the potential to enhance the understanding and treatment of HIV.
Latest Patents
Haijuan Li holds a patent for a method, assay, and kit for quantifying HIV protease inhibitors. This method involves combining HIV protease, a conjugate comprising an HIV protease inhibitor analog, and a sample suspected of containing an HIV protease inhibitor. The process allows for the formation of a detectable complex, which can be measured to determine the concentration of the HIV protease inhibitor in the sample. He has 1 patent to his name.
Career Highlights
Li is currently employed at Roche Diagnostics Operations, Inc., where he applies his expertise in developing innovative solutions for healthcare challenges. His work is instrumental in advancing diagnostic methods that can lead to better patient outcomes.
Collaborations
Some of his notable coworkers include Herbert Von Der Eltz and Lili Arabshahi, who contribute to the collaborative environment at Roche Diagnostics Operations, Inc. Their combined efforts foster innovation and drive research forward.
Conclusion
Haijuan Li's contributions to the field of HIV research exemplify the impact of innovative thinking in healthcare. His patented method for quantifying HIV protease inhibitors represents a significant advancement in the fight against HIV.